Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir Mehta

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|November 16, 2005
Differences in the management and prognosis of women and men who suffer from acute coronary syndromesSonia S Anand, Chang Chun Xie, Shamir Mehta, et al.
American Heart Journal|October 18, 2008
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular diseaseBenjamin A Steinberg, Deepak L Bhatt, Shamir Mehta, et al.
Critical Pathways in Cardiology|August 2, 2007
An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registryBenjamin A Steinberg, Christie M Ballantyne, Deepak L Bhatt, et al.
Medicine|August 24, 2019
Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysisSaurabh Gupta, Emilie P Belley-Côté, Bram Rochwerg, et al.
American Heart Journal|December 22, 2005
Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevationElizabeth M Mahoney, Shamir Mehta, Yong Yuan, et al.
Interactive Cardiovascular and Thoracic Surgery|August 11, 2020
Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysisSaurabh Gupta, Emilie P Belley-Cote, Puru Panchal, et al.
European Heart Journal|October 11, 2005
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary interventionPeter R Sinnaeve, John Simes, Salim Yusuf, et al.
Journal of Thrombosis and Thrombolysis|July 17, 2012
Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirinYan Liang, Marilyn Johnston, Jack Hirsh, et al.
Implementation Science : IS|April 22, 2021
Impact of provincial and national implementation strategies on P2Y12 inhibitor utilization for acute coronary syndrome in the elderly: an interrupted time series analysis from 2008 to 2018Saurabh Gupta, Emilie P Belley-Cote, Adam Eqbal, et al.
Echocardiography (Mount Kisco, N.Y.)|April 8, 2014
Incremental value of left ventricular systolic and diastolic function to determine outcome in patients with acute ST-segment elevation myocardial infarction: the echocardiographic substudy of the OASIS-6 trialHisham Dokainish, Mahadevan Rajaram, Dorairaj Prabhakaran, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|November 16, 2005
Differences in the management and prognosis of women and men who suffer from acute coronary syndromesSonia S Anand, Chang Chun Xie, Shamir Mehta, et al.
American Heart Journal|October 18, 2008
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular diseaseBenjamin A Steinberg, Deepak L Bhatt, Shamir Mehta, et al.
Critical Pathways in Cardiology|August 2, 2007
An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registryBenjamin A Steinberg, Christie M Ballantyne, Deepak L Bhatt, et al.
Medicine|August 24, 2019
Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysisSaurabh Gupta, Emilie P Belley-Côté, Bram Rochwerg, et al.
American Heart Journal|December 22, 2005
Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevationElizabeth M Mahoney, Shamir Mehta, Yong Yuan, et al.
Interactive Cardiovascular and Thoracic Surgery|August 11, 2020
Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysisSaurabh Gupta, Emilie P Belley-Cote, Puru Panchal, et al.
European Heart Journal|October 11, 2005
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary interventionPeter R Sinnaeve, John Simes, Salim Yusuf, et al.
Journal of Thrombosis and Thrombolysis|July 17, 2012
Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirinYan Liang, Marilyn Johnston, Jack Hirsh, et al.
Implementation Science : IS|April 22, 2021
Impact of provincial and national implementation strategies on P2Y12 inhibitor utilization for acute coronary syndrome in the elderly: an interrupted time series analysis from 2008 to 2018Saurabh Gupta, Emilie P Belley-Cote, Adam Eqbal, et al.
Echocardiography (Mount Kisco, N.Y.)|April 8, 2014
Incremental value of left ventricular systolic and diastolic function to determine outcome in patients with acute ST-segment elevation myocardial infarction: the echocardiographic substudy of the OASIS-6 trialHisham Dokainish, Mahadevan Rajaram, Dorairaj Prabhakaran, et al.
Pageof 7